FindTrial
Sign In

Real-world clinical demonstration and extension research on Mongolian medicine's Brain-White Meridian regulating acupuncture in the treatment of convalescent stroke patients

Real-world clinical demonstration and extension research on Mongolian medicine's Brain-White Meridian regulating acupuncture in the treatment of convalescent stroke patients

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ITMCTR
Registry ID
ITMCTR2024000844
Enrollment
Unknown
Registered
2024-12-18
Start date
2024-12-31
Completion date
Unknown
Last updated
2025-01-06

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

recovery period of stroke

Interventions

Galasa (one of the Mongolian medicine classifications of stroke) spasm phase:Mongolian medicine's Brain-White Meridian regulating acupuncture+ Rehabilitation Therapy
Galasa (one of the Mongolian medicine classifications of stroke)separate movement phase:Mongolian medicine's Brain-White Meridian regulating acupuncture+ Rehabilitation Therapy
Wusunsa (one of the Mongolian medicine classifications of stroke) spasm phase:Mongolian medicine's Brain-White Meridian regulating acupuncture+ Rehabilitation Therapy
Wusunsa (one of the Mongolian medicine classifications of stroke)separate movement phase:Mongolian medicine's Brain-White Meridian regulating acupuncture+ Rehabilitation Therapy
Galasa (one of the Mongolian medicine classifications of stroke) latency period:Mongolian medicine's Brain-White Meridian regulating acupuncture+ Rehabilitation Therapy
Wusunsa (one of the Mongolian medicine classifications of stroke) latency period:Mongolian medicine's Brain-White Meridian regulating acupuncture+ Rehabilitation Therapy

Sponsors

International Mongolian Hospital of Inner Mongolia
Lead Sponsor

Eligibility

Sex/Gender
All
Age
20 Years to 75 Years

Inclusion criteria

Inclusion criteria: 1) Diagnosis of stroke during the recovery phase in accordance with the "Guidelines and Consensus for the Diagnosis and Treatment of Cerebrovascular Diseases in China (2016 Edition)," confirmed by cranial CT or MRI, or consistent with the diagnosis and classification of "Encyclopedia of Chinese Medicine - Mongolian Medicine Volume (1986 Edition)" for Sar disease, with lesions confined to the cerebral hemisphere; 2) Onset 2 weeks to 6 months prior; 3) Clear consciousness and stable vital signs; 4) Individuals who have signed the treatment consent form.

Exclusion criteria

Exclusion criteria: 1) Patients with stroke indicated by cranial CT or MRI in the brainstem or cerebellum; 2) Individuals with consciousness disorders, unstable vital signs, or quadriplegia; 3) Patients with concomitant hemolytic diseases, thrombocytopenic disorders, or malignant tumors; 4) Individuals with severe musculoskeletal diseases (affecting limb weight-bearing) or severe heart, lung, or kidney dysfunction; 5) Patients with severe post-stroke depression, sensory aphasia, mental disorders, or severe dementia.

Design outcomes

Primary

MeasureTime frame
Hoffer Walking Ability Scale;Ashworth Scale;Fugl-Meyer;NIHSS;—

Secondary

MeasureTime frame
Watanabe Classification;FIM (Functional Independence Measure) scale;Addenbrooke;Berg Balance Scale (BBS);Chinese Standard Aphasia Screening Test;—

Countries

China

Contacts

Public ContactYao Hass

International Mongolian Hospital of Inner Mongolia

Yaohasi@126.com13848150360

Outcome results

None listed

Source: ITMCTR (via WHO ICTRP) · Data processed: Feb 4, 2026